A radioligand is a microscopic particle which consists of a therapeutic radioactive isotope and the cell-targeting compound - the ligand. The ligand is...
35 KB (4,347 words) - 18:33, 11 August 2024
radioligand concentration is high enough to saturate the protein. Denatured protein is unable to bind the radioligand and the protein and radioligand...
47 KB (5,530 words) - 12:05, 4 January 2024
PET radiotracer (redirect from PET radioligand)
PET radiotracer is a type of radioligand that is used for the diagnostic purposes via positron emission tomography imaging technique. PET is a functional...
4 KB (275 words) - 19:08, 26 August 2023
DRUGMATRIX: Muscarinic M1 radioligand binding (Ligand: [3H] N-Methylscopolamine) - PubChem". "AID 625154 - DRUGMATRIX: Muscarinic M4 radioligand binding (Ligand:...
12 KB (1,032 words) - 20:15, 7 September 2024
Ligand binding assay (redirect from Radioligand binding assay)
for a radioligand (per mole) are referred to as the specific activity (SA), which is measured in Ci/mmol. The actual concentration of a radioligand is determined...
33 KB (4,103 words) - 18:40, 30 July 2024
competitive.[citation needed] In this type of assay, a single concentration of radioligand (usually an agonist) is used in every assay tube. The ligand is used...
10 KB (1,084 words) - 20:25, 28 August 2024
Nix WB, Timmerman H, Leurs R (July 2002). "A novel phenylaminotetralin radioligand reveals a subpopulation of histamine H(1) receptors". The Journal of...
21 KB (1,711 words) - 17:59, 7 September 2024
Schild equation (section Radioligand binding assays)
In pharmacology, Schild regression analysis, based upon the Schild equation, both named for Heinz Otto Schild, are tools for studying the effects of agonists...
9 KB (1,234 words) - 21:48, 22 January 2024
Radionuclide therapy (redirect from Radioligand therapy)
(such as with Lutathera and Pluvicto), the technique is also known as radioligand therapy. Iodine-131 (131I) is the most common RNT worldwide and uses...
12 KB (1,294 words) - 12:04, 7 September 2024
cancer (mCRPC). Lutetium (177Lu) vipivotide tetraxetan is a targeted radioligand therapy. The most common adverse reactions include fatigue, dry mouth...
19 KB (1,360 words) - 05:12, 15 September 2024